OKYO Pharma Ltd (OKYO) reporting calendar
OKYO Pharma Ltd files periodic reports with the SEC as OKYO on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Mar 2026
- Filed
- 20 Jul 2026
- Reports on record
- 5
Open OKYO market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Mar 2026 | 20 Jul 2026 | 111 days | 0001493152-26-033847 |
| 20-F | 31 Mar 2025 | 18 Jul 2025 | 109 days | 0001641172-25-020240 |
| 20-F | 31 Mar 2024 | 13 Aug 2024 | 135 days | 0001493152-24-031640 |
| 20-F | 31 Mar 2023 | 15 Aug 2023 | 137 days | 0001493152-23-028739 |
| 20-F | 31 Mar 2022 | 15 Aug 2022 | 137 days | 0001493152-22-022836 |
Source: SEC EDGAR company submissions for CIK 0001849296. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.